Literature DB >> 34020272

Rapid and automated quantitation of dense red blood cells: A robust biomarker of hydroxyurea treatment response.

Alina Sadaf1, Charles T Quinn2, Jennifer B Korpik3, Amanda Pfeiffer4, Mary Reynaud3, Omar Niss5, Punam Malik5, Russell E Ware5, Theodosia A Kalfa2, Patrick T McGann6.   

Abstract

Entities:  

Keywords:  Biomarkers; Hydroxyurea; MCHC; Sickle cell anemia

Mesh：

Substances：

Year:  2021        PMID： 34020272      PMCID： PMC8829804          DOI： 10.1016/j.bcmd.2021.102576

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN： 1079-9796            Impact factor:   2.372


× No keyword cloud information.
  8 in total

1.  Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.

Authors:  Kenneth I Ataga; Wally R Smith; Laura M De Castro; Paul Swerdlow; Yogen Saunthararajah; Oswaldo Castro; Elliot Vichinsky; Abdullah Kutlar; Eugene P Orringer; Greg C Rigdon; Jonathan W Stocker
Journal:  Blood       Date:  2008-01-11       Impact factor: 22.113

2.  Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia.

Authors:  Patrick T McGann; Omar Niss; Min Dong; Anu Marahatta; Thad A Howard; Tomoyuki Mizuno; Adam Lane; Theodosia A Kalfa; Punam Malik; Charles T Quinn; Russell E Ware; Alexander A Vinks
Journal:  Am J Hematol       Date:  2019-06-12       Impact factor: 10.047

3.  Sickle cell dehydration: Pathophysiology and therapeutic applications.

Authors:  Carlo Brugnara
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

4.  Intracellular polymerization of sickle hemoglobin. Effects of cell heterogeneity.

Authors:  C T Noguchi; D A Torchia; A N Schechter
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

5.  A simple laboratory alternative to irreversibly sickled cell (ISC) counts.

Authors:  M R Clark; N Mohandas; S H Embury; B H Lubin
Journal:  Blood       Date:  1982-09       Impact factor: 22.113

Review 6.  Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication.

Authors:  Charles T Quinn
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-23

7.  Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).

Authors:  Kenneth I Ataga; Marvin Reid; Samir K Ballas; Zahida Yasin; Carolyn Bigelow; Luther St James; Wally R Smith; Frederic Galacteros; Abdullah Kutlar; James H Hull; Jonathan W Stocker
Journal:  Br J Haematol       Date:  2011-02-17       Impact factor: 6.998

8.  Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis.

Authors:  Pablo Bartolucci; Carlo Brugnara; Armando Teixeira-Pinto; Serge Pissard; Kamran Moradkhani; Hélène Jouault; Frederic Galacteros
Journal:  Blood       Date:  2012-08-23       Impact factor: 22.113
  8 in total
  1 in total

1.  Size and density measurements of single sickle red blood cells using microfluidic magnetic levitation.

Authors:  Utku Goreke; Allison Bode; Sena Yaman; Umut A Gurkan; Naside Gozde Durmus
Journal:  Lab Chip       Date:  2022-02-15       Impact factor: 7.517
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.